April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Crispin Hiley: Stephanie Saw on Post-Osimertinib Decision Making in EGFR+ NSCLC
Mar 27, 2025, 13:04

Crispin Hiley: Stephanie Saw on Post-Osimertinib Decision Making in EGFR+ NSCLC

Crispin Hiley, UK Clinical Director for Lung Cancer at GenesisCare, shared a post on X:

“Slick discussion of complexity post Osimertinib decision making for patients with EGFR mutation positive NSCLC by Stephanie Saw – it’s a good problem to have in 2025.”

Crispin Hiley